Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12115130-B2

Patent

Publication Date

2024-10-15

Expiration Date


Abstract

A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.

Core Innovation

The invention relates to a solid dosage form for active ingredient release, in particular a tablet, comprising a three-dimensional base body with an active ingredient. The tablet further comprises a portion having a structure forming a two-dimensional identifier, and the portion is integral with the three-dimensional base body, so that the identifier structure is formed as part of the tablet rather than as a separate added element.

A central objective addressed is improving unambiguous authentication while increasing medicament safety. Compared with prior approaches that use punching tablets and separately printed, easily damaged two-dimensional codes, the integral portion is described as being less easy to remove. The patent emphasizes that authentication can be supported by a two-dimensional identifier such as a QR code, barcode, or haptic code that remains associated with the medicament.

The patent also describes forming the portion by screen printing, including providing a first printing paste comprising an active ingredient and applying it by means of a first printing screen. A second printing paste comprising a colouring agent is then applied by means of a second printing screen to form a portion whose structure forms the two-dimensional identifier, where the pattern of the second printing screen defines the structure. The portion can be configured on a surface, as a protrusion or planar structure, or enclosed, and the identifier is described as readable in different ways including by eyes, haptics, or smartphone camera, with optional detectability after administration using a detectable marker.

Claims Coverage

The document provides two independent claims. The independent claims cover an integral tablet portion forming a two-dimensional identifier and a screen-printing production method using two pastes to form that identifier portion.

Integral two-dimensional identifier portion on an active-ingredient tablet

A solid dosage form for active ingredient release, in a tablet comprising a three-dimensional base body with an active ingredient, and a portion integral with the three-dimensional base body, the portion having a structure forming a two-dimensional identifier.

Two-paste screen printing forming a two-dimensional identifier portion

A method for production by means of screen printing of a dosage form, comprising providing a first printing paste comprising an active ingredient and applying it by means of a first printing screen, providing a second printing paste comprising a colouring agent and applying it by means of a second printing screen to form a portion of the dosage form having a structure forming a two-dimensional identifier, wherein a pattern of the second printing screen defines a structure of the portion.

Overall, the claims focus on an integral tablet portion that structurally forms a two-dimensional identifier and on a screen-printing method using first and second printing pastes, where the second printing screen pattern defines the two-dimensional identifier portion.

Stated Advantages

Improved unambiguous authentication of the medicament.

Increased medicament safety because the two-dimensional identifier cannot be easily removed.

Documented Applications

Authentication of a medicament using an integrated two-dimensional identifier on an active-ingredient tablet.

Detectability after administration using a marker and imaging methods, including the concept of imaging-based detection after administration.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.